Timothée David

1 month ago | jnm.snmjournals.org | Julie Constanzo |Timothée David |Aliasghar Parach |Joshua Karam

radioimmunotherapytargeted radionuclide therapy225Acmicroenvironmentbystander immunityT-cell adaptive immunityTumor absorbed dose and tumor volume are among the main parameters involved in the assessment of external beam radiation therapy (EBRT) efficacy (1). In contrast, although absorbed dose or volume changes are considered in radiopharmaceutical therapy (RPT), they are not considered at the therapy planning stage (2).

Jan 21, 2025 | bpspubs.onlinelibrary.wiley.com | Timothée David |ICM Montpellier France |Aude Mallavialle |Valérie Laurent-Matha

CONFLICT OF INTEREST STATEMENT No potential conflicts of interest were disclosed by all authors. Supporting Information Filename Description bph17437-sup-0001-Supporting_Information.pdfPDF document, 1.5 MB Figure S1. Immunotherapy of TNBC with the F1 anti-cathepsin-D antibody. Figure S2. Immunotherapy with anti-cathepsin-D antibodies triggers both innate and adaptive antitumour immunity in an immunocompetent mouse model of triple-negative breast cancer (TNBC). Figure S3.

Dec 10, 2023 | theconversation.com | Clea Chakraverty |Thomas Leite |Timothée David |Victoire N'Sondé

Depuis le 6 novembre, le Parlement discute la nouvelle loi « immigration » portée par le ministre de l’Intérieur Gérald Darmanin. Si adoptée, elle pourrait constituer la trentième loi sur l’immigration depuis 1980. Durant la campagne pour l’élection présidentielle de 2022, l’immigration a été le deuxième sujet le plus évoqué par les candidats. Nous vous proposons ici une série d’articles revenant sur certains points clefs de la politique migratoire française et de leurs impacts dans la société.

Nov 29, 2023 | bpspubs.onlinelibrary.wiley.com | Timothée David |Univ Montpellier |Aude Mallavialle |ICM Montpellier France

Supporting Information Filename Description bph16291-sup-0001-supplemental.pdfPDF document, 794.5 KB Data S1. Supporting Information bph16291-sup-0002-sup marked.docxWord 2007 document , 35.7 KB Figure S1. CathD expression and secretion in the 4T1 murine TNBC cell line. Whole cell extracts (lysate, 20 μg proteins) and 24-hour conditioned media (SN, 40 μl) were separated by 13.5% SDS-PAGE and immunoblotted with an anti-mouse CathD antibody (#AF1029).